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ABSTRACT

The α2 isoform of collagen IV’s noncollagenous 1 domain (α2NC1 or
canstatin) has shown promise as an anti-cancer molecule, possessing both
angiostatic and pro-apoptotic properties. This work aims to further the knowledge
of α2NC1 by conducting a truly in vivo study in which the Gal4-induced
endogenous overexpression of α2NC1 in Drosophila melanogaster will be used
to assess the effects of α2NC1 upon normal development as well as
tumorigenesis. To this end, transgenic fly lines capable of overexpressing α2NC1
were created. Initial overexpression studies indicated no developmental
phenotype was caused by abundance of α2NC1. However, future overexpression
studies in which α2NC1 is exported to its native extracellular location may reveal
roles for α2NC1 in normal development and/or tumorigenesis.

Keywords: NC1, basement membrane, development, cancer, angiogenesis,
Drosophila melanogaster
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CHAPTER 1

INTRODUCTION
One often hears someone mention finding “the cure” for cancer. However,
no two cancers are exactly alike; rather, “cancer” refers to any unchecked
proliferation of cells. This rapid growth causes tumors to form. There are several
factors which confer on tumors the ability to continuously grow and ultimately
metastasize. Such hallmarks of cancer include the evasion of apoptosis
(programmed cell death), sustained angiogenesis (the formation of new blood
vessels), self-sustaining growth signals, and insensitivity to anti-growth signals
(1). Research focused on each of these cancer hallmarks is needed in order to
combat the various subtypes that encompass this disease.
One such area of research focuses on basement membrane, whose
components play numerous important roles in the formation, growth, and
spreading of tumors. Basement membrane, or “BM”, is the 50-100nm-thick
specialized extracellular matrix that lines both layers of epithelial cells and the
endothelial cells that line blood vessels (2). BM plays an important structural role,
separating monolayers of epithelia from stroma or neighboring tissue and
providing support. It is also important in numerous biochemical capacities, as
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components of BM have been shown to modulate signaling across the cell
membrane (2,3). Such signals promote cell migration, differentiation, and growth
and can vary depending on the unique microenvironment created by the BM
components, many of which have tissue-specific isoforms (2,3,4).
One such component of BM is collagen IV (2,3,4). The genes for collagen
IV are highly conserved across species (5) and code for six distinct isoforms of
the α-chain, which differ primarily within their globular C-terminal noncollagenous
(NC1) domains (2-6). α-chains self-assemble in the extracellular space to form
the complex collagen IV suprastructure shown in Figure 1.1. In the first step of
self-assembly, NC1 domains coordinate the association of three α-chains into
trimers referred to as protomers. Several unique combinations of α-chain
isoforms have been observed, with α1α1α2 being the most common (2,3,6). Two
protomers associate into a hexamer of α-chains via thioester bonds between
conserved methionine and lysine residues present in each NC1. Each
methionine bonds with the lysine on the opposite NC1 residue, and vice-versa
(2). Interactions between the N-terminal 7S domains mediate the tetrameric
association of hexamers to form the “spider-like” shape characteristic of the
collagen IV matrix (2,3).
There are several other components of BM, most of which are proteins
and glycoproteins (2,3,5). The second-most abundant component is the
glycoprotein laminin which, like collagen IV, self-assembles into a network
composed of laminin trimers (in this case, heterotrimers, each consisting of an α,
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β, and γ subunits). A variety of laminin isoforms contributes to the heterogeneity
observed within individual BMs and between BMs of various tissues (2,3).
Additionally, the presence of less abundant collagens (i.e. collagen XV and
collagen XVIII) lends specificity to particular BMs. Other protein components
include nidogen/entactin (which links the collagen and laminin scaffolds),
heparan-sulphate proteoglycans (such as perlecan and agrin, which sequester
stores of vascular endothelial growth factor), SPARC/BM-40/osteopontin), and
fibulins (3). Not only are each of these proteins structurally important for BM, but
nearly all of them have been shown to regulate angiogenesis during remodeling
(2,3).
BM is anchored to the basolateral side of epithelium and endothelium
primarily by interactions between the five G-like (LG) domains of laminin α-chains
and cell-surface molecules including integrins and dystroglycans (2,3,6,7).
Specifically, LG1-3 have been shown to bind integrins α3β1, α6β1, α7β1, &
α6β4, while LG4-5 bind α-dystroglycan (7,8). However, the chemical natures of
these interactions remain unknown (8). Additionally, interactions between the
triple-helical region of collagen IV and integrins α1β1 & α2β1 further promote
cellular adhesion (6).
BM components are continuously turned over (degraded and reformed) in
a process called BM remodeling. While BM remodeling occurs at a normal basal
level in all tissues, it plays a particularly important role in processes such as
development and angiogenesis. For example, in Drosophila melanogaster each
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adult tissue begins as an “imaginal disc” or precursor tissue, in the Drosophila
larva. Each disc is surrounded by a basement membrane which is turned over
during disc eversion, the process by which the imaginal discs develop into adult
tissues (9). Due to this critical role of BM remodeling, Drosophila is an excellent
model organism for studying the effects of BM components on development, a
research topic with which the reagents created in this study will aid.
However, the relevance of BM remodeling on development extends well
beyond the fly, as it is important for the development and partitioning of tissues in
all multicellular animals (2,3,10,11). For example, in mice and other mammals,
the specialized basement membrane of the kidney glomerulus (GBM) is formed
during embryonic development from the remodeling and fusion of two distinct
BMs – one synthesized by glomerular epithelium and the other by glomerular
endothelium. Failure of the GBM to form properly will result in an incompletely
vascularized glomerulus and a leaky blood-urine barrier (11).
BM remodeling is also required for the proliferation and migration of
endothelial cells to form new blood vessels in the process of angiogenesis. Not
only is BM degradation needed in a physical sense, to un-anchor endothelial
cells and provide space for a new branch of the blood vessel, but many of the
protein fragments generated during remodeling promote angiogenesis and
endothelial cell migration (2,3). Furthermore, stores of vascular endothelial
growth factor (VEGF) that were previously sequestered in the BM are released
during remodeling (2,3).
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As previously mentioned, angiogenesis is critical for tumor growth and
metastasis, as new blood vessels are needed if the growing tumor is to receive
the nutrients required for rapid and continued growth. Tumors often therefore
upregulate factors, such as matrix metalloproteases (MMPs), which degrade BM
and promote blood vessel formation (5). In addition to providing nutrients, these
new vessels also provide access to the bloodstream – a single cancerous cell
may break off from the primary tumor, enter the blood stream, and exit the blood
stream in another tissue, forming secondary tumors (Figure 1.2). This is the
process of metastasis and the most clinically devastating feature of cancer.
Given the numerous pro-angiogenic factors generated by BM remodeling,
it makes sense that there would be a subsequent signal to “turn off”
angiogenesis. This seems to be the role of collagen IV’s C-terminal noncollagenous 1 (NC1) domain. NC1 is one of the smallest and last products to be
generated by MMPs in the degradation of BM, and several of its isoforms have
been shown to inhibit angiogenesis (2-6,12-14). One particularly potent isoform is
that of the α2 chain, or α2NC1 (also called canstatin in some literature). This
25KDa molecule has been shown to decrease tumor growth and metastasis by
inhibiting two cancer strategies – sustained angiogenesis and evasion of
apoptosis.
Several studies have demonstrated the angiostatic and pro-apoptotic
properties of α2NC1 (and other NC1 isoforms) (4,6,12-14). Many of these studies
were conducted in vitro, using HUVECs (human umbilical vein endothelial cells)
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to demonstrate decreased growth, migration, & tubal formation as well as
increased apoptosis of these cells when treated with α2NC1 (4,12). Others were
conducted in xenograft models, in which human cancer cells were implanted
subcutaneously in mice to mimic “natural” tumors. These studies showed
decreased vascularization and growth of implanted tumors when treated with
α2NC1, either by direct injection or injection of an adenovirus coding for α2NC1
(4,12,13). Extension of α2NC1’s half-life by fusing it to human serum albumin
(HSA) resulted in a more dramatic anti-tumor effect and was even shown to
decrease the levels of metastasis in mice (12,13). Whether or not α2NC1
promotes apoptosis in tumor cells as well as endothelial cells remains
controversial, as α2NC1-HSA was shown to have a pro-apoptotic effect but
unfused α2NC1 was not (4,12-14).
Several studies have investigated the mechanism by which α2NC1 elicits
its effects. One possible anti-angiogenic mechanism of α2NC1 was proposed by
Petitclerc et al., who suggested that soluble NC1 binds along the triple-helical
region of collagen IV, thereby disrupting the lateral associations of collagen IV
with other BM components (i.e. the laminin scaffold) and cell-surface anchors
(specifically β1 integrins). As a result, the basement membrane assembly
required for blood vessel formation is obstructed and angiogenesis is prevented
(6).
More research has been done, however, based on the results of a study
by Magnon et al. which found that α2NC1 binds to αv integrins including αvβ3
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and αvβ5. Interactions between αv integrins and BM components have been
shown to mediate migration of endothelial and tumor cells. It is therefore thought
that the binding of α2NC1 to αv integrins blocks BM-integrin interaction and
thereby inhibits the migration of endothelial and tumor cells seen in angiogenesis
and metastasis (12). A later study by Magnon et al. demonstrated that due to
these interactions with αv integrins, α2NC1 is even more effective at decreasing
tumor angiogenesis and growth when paired with standard radiation therapy, as
radiation increases expression of αvβ3 and αvβ5 integrins (13).
Additionally, α2NC1-integrin interactions have been shown to induce
caspase-8 dependent apoptosis in endothelial cells by increasing Fas ligand
expression and downregulating the expression of the anti-apoptotic protein FLIP
via the disruption of FAK/PI3K/Akt signaling (12,14). Downregulation of FLIP
decreases the mitochondrial membrane potential, causing the release of
cytochrome c which results in caspase-9 activation. Caspase-9 dependent
apoptosis was demonstrated in α2NC1-treated endothelial cells and in α2NC1HSA-treated tumor cells (12,14). Furthermore, Petitclerc et al. imply that, like
previously-studied αvβ3 antagonists, α2NC1 may elicit its pro-apoptotic effect by
disrupting signal transduction pathways leading to altered expression/activity of
Bcl-2, Bax, and p53 (6).
To further investigate the roles of α2NC1, we proposed a unique in vivo
study in which α2NC1 would be endogenously overexpressed within a wellstudied model organism, Drosophila melanogaster (the fruit fly). Endogenous
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overexpression in otherwise wild-type flies will allow us to observe the effects of
α2NC1 on normal organismal development. In subsequent experiments, α2NC1
will be overexpressed in flies with mutations in the genes Ras (a conserved and
much-studied oncogene) and scribble (a conserved cell polarity protein whose
inactivation disrupts cell polarity, inhibits apoptosis and induces dysplasia). This
double mutation results in tumors which display features of human metastatic
tumors. For example, these tumors result in the loss of cell-cell junctions and cell
polarity (15). By comparing the size and number or tumors observed in α2NC1overexpressing flies versus “normal” Ras/scribble flies, we will be able to assess
α2NC1’s effect upon tumorigenesis.
To achieve the overexpression of α2NC1 in flies, we chose to utilize the
powerful UAS-Gal4 binary genetic technique. The various elements of this
powerful genetic system were originally identified in yeast and manipulated later
for use in Drosophila. Gal4 is a transcriptional activator which binds to a specific
sequence of DNA called an upstream activator sequence (UAS), resulting in
robust transcription of any downstream gene (16) (Figure 1.3).
In this thesis, work related to cloning of α2NC1 in pUAST and subsequent
generation of transgenic flies is presented. Two types of UAS- α2NC1 flies were
created - one with the signal sequence (that aids in the secretion of the protein)
and the other without this sequence resulting in one set of flies capable of
secreting the protein and the other set where the secretion would be impaired.
These two reagents will aid in better understanding of the consequences of
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α2NC1 overexpression on normal development and tumor progression in a living
organism.
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Figure 1.1 Structure of Collagen IV. The collagen IV suprastructure is formed
by the self-assembly of various α-chains (each ~400nm). In addition to a central
collagenous domain characterized by a repeated Gly-X-Y motif in which X and Y
are most often hydroxyproline and hydroxylysine, each α-chain contains an Nterminal 7S domain and a C-terminal noncollagenous domain. NC1 domains
initiate the association of three α-chains into a trimer or “protomer”. Two
protomers interact via their NC1 domains, forming a hexamer. Hexamers interact
via their 7S domains to form a spider-like tetramer. Bridging of multiple tetramers
creates the fibrous collagen IV network that comprises more than 50% of the
basement membrane (2,3). Source: Kalluri, R., et al. (3)
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Figure 1.2. Angiogenesis and Metastasis. Tumors promote angiogenesis in
order to receive the nutrients required for continued growth. As illustrated, the
events of tumor angiogenesis and basement membrane degradation are closely
linked. New blood vessels provide easy access to the blood stream, allowing
tumors to metastasize. Source: Adapted from Zetter, B. R. (17)
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Figure 1.3. Binding of Gal4 to the Upstream Activation Sequence Causes
Robust Expression of a Downstream Gene (NC1). The UAS-Gal4 system has
been manipulated for use in Drosophila in order to overexpress genes of interest.
In this study, crossing transgenic UAS-α2NC1 males with Gal4 driver females
results in progeny which overexpress NC1. Source: Adapted from Heberlein, U.,
et al. (18)
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CHAPTER 2

METHODS
PCR Amplification of α2NC1 cDNA:
The DNA sequence for α2NC1 was amplified from Viking cDNA via PCR.
120ng Viking cDNA, 100ng each of primers JO1US and JO1DS (Table 2.1), 5µl
of 5nM dNTPs (Invitrogen), 5µl of 10X Pfu Turbo Buffer (Agilent Technologies,
Inc.), 1µl of Pfu (Agilent Technologies, Inc.), and nanopure water to 50µl were
included in PCR reaction. Thermal cycler conditions were as follows: 5 minutes
at 94oC, 35X (2 minutes at 94oC, 1 minute at 56oC, 1.5 minutes at 72oC), 10
minutes at 72oC. The PCR products were run on a 0.8% agarose gel with
0.6µg/mL ethidium bromide at 100V for 1hr, and the band corresponding to
α2NC1 (~900bp) was excised and purified using QIAGEN’s Qiaex II Gel
Extraction Kit, according to the manufacturer’s protocol.

Digestion of α2NC1:
Purified α2NC1 DNA and Bluescript II SK+ (BS) DNA were each doubledigested with EcoRI and XbaI as follows: 1μg α2NC1 or 40μg BS DNA, 10μl 10X
Buffer M (Invitrogen), 2.5μl EcoRI (~25U, Invitrogen), 2.5μl (~25U, Invitrogen),
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and nanopure water to 100μl. Digestions took place in a thermal cycler at 37oC
for 2 hours. The digests were run on a 0.8% agarose gel with 0.6µg/mL ethidium
bromide at 100V for 1hr and the bands corresponding to α2NC1 (~900bp) and
BS (~3000bp) were excised and the DNA purified using the QIAGEN Qiaex II Gel
Extraction Kit according to the manufacturer’s protocol.

Ligation of α2NC1 into Bluescript II SK+:
113ng digested BS and 113ng digested α2NC1 (3:1 molar ratio) were
ligated in a 10µl reaction which also contained 1µl of 10X T4 DNA Ligase Buffer
(New England Biolabs), 0.5µl T4 DNA Ligase (New England Biolabs), and
nanopure water. The ligation took place overnight (18 hours) at 10oC. The entire
ligation (10µl) reaction was used to transform chemically-competent DH5α E. coli
via heat shock. Heat shock was carried out by incubating the ligation reaction
with 50µl cells for 20 minutes on ice, followed by 90 seconds on a 42oC heat
block and another 3 minutes on ice. Cells were then given 300µl LB media and
incubated at 37oC for 45 minutes. Transformants were selected by growing the
cells overnight at 37oC on LB-agar with 75µg/mL ampicillin.

Screening of Transformants for Recombinant BS-α2NC1:
4mL liquid LB/ampicillin (75µg/mL) cultures were inoculated with each of
the forty-two resulting transformants and grown overnight at 37oC/300rpm.
Plasmid DNA was isolated from each of these liquid cultures using Qiagen’s
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QIAprep Spin Miniprep Kit according to the manufacturer’s protocol. Isolated
plasmid DNA was run on a 0.8% agarose gel with 0.6µg/mL ethidium bromide at
100V for 1hr. DNA from putative positive clones was double-digested with EcoRI
and XbaI for two hours at 37oC (200ng plasmid DNA, 0.5μl each enzyme [~5U,
Invitrogen], 2μl 10X Buffer M [Invitrogen], nanopure water to 20μl) and run on a
0.8% agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Miniprepped
DNA from a confirmed BS-α2NC1 clone was used to transform chemicallycompetent DH5α E. coli cells via heat shock (as previously described). A
resulting colony was used to inoculate a 4mL liquid LB/ampicillin (75µg/mL)
culture, which was grown for 14 hours at 37oC/300rpm. 500µl of this starter
culture was used to inoculate a 100mL liquid LB/ampicillin (75µg/mL) culture,
which was grown up overnight, also at 37oC/300rpm. Plasmid DNA was isolated
using Qiagen’s Spin Maxiprep Kit according to the manufacturer’s protocol.

Subcloning of α2NC1 from BS-α2NC1 to pUAST:
BS-α2NC1 and pUAST were double-digested with EcoRI and XbaI
(47.3µg of BS-α2NC1 or 42.5µg pUAST, 2.5μl each enzyme [~25U, Invitrogen],
10μl 10X Buffer M [Invitrogen], nanopure water to 100μl). Digests were run on a
0.8% agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr, and the
bands corresponding to α2NC1 (~900bp) and pUAST (~9000bp) were gel
extracted using Qiagen’s Qiaex II Gel Extraction Kit according to the
manufacturer’s protocol. The digested α2NC1 and pUAST were ligated in a 3:1
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ratio (150ng digested pUAST, 50ng α2NC1, 0.5µl T4 DNA Ligase [200U, NEB],
1µl 10X Buffer [NEB], nanopure water to 10µl) overnight (14 hours) at 10oC
using. The entire ligation reaction (10µl) was used to transform chemicallycompetent DH5α E. coli using the previously-described heat shock protocol.
Transformants were selected by growing the cells overnight at 37oC on LB-agar
plates with 75µg/mL ampicillin.

Screening of Transformants for Recombinant pUAST-α2NC1:
4mL liquid LB/ampicillin (75µg/mL) cultures were inoculated with each of
the eighteen resulting transformants and grown overnight at 37oC/300rpm.
Plasmid DNA was isolated from each of these liquid cultures using Qiagen’s
QIAprep Spin Miniprep Kit according to the manufacturer’s protocol. Isolated
plasmid DNA was run on a 0.8% agarose gel with GelRed (Biotium) at 100V for
1hr. The identity of a putative positive clone was confirmed by amplifying α2NC1
from it via PCR. The PCR reaction included 1μg plasmid DNA, 100ng each of
primers JO1US and JO1DS (Table 2.1), 45μl PCR Supermix (Invitrogen), and
nanopure water to 50μl. Thermal cycler conditions were as follows: 5 minutes at
94oC, 35X(2 minutes at 94oC, 1 minute at 56oC, 1.5 minutes at 72oC), 10 minutes
at 72oC. 20μl of the PCR products were run on a 0.8% agarose gel with
0.6µg/mL ethidium bromide at 100V for 1hr. DNA from the positive clone was
used to transform chemically-competent DH5α E. coli via heat shock (as
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previously described) and maxiprep pUAST-α2NC1 using the Qiagen Spin
Maxiprep Kit according to the manufacturer’s protocol.

Standard Dideoxy Sequencing of pUAST-α2NC1:
The α2NC1 DNA sequence was PCR amplified using the following
conditions: 10pmol of primer UAAS-2 or pUASTrev (Table 2.1), 12ng pUASTα2NC1 (template DNA), 2µl 5X BigDye Sequencing Juice, and 2µl 5X buffer.
Thermal cycler conditions were as follows: 3min at 96oC, 25X (30sec at 96oC,
15sec at 50oC, 4min at 60oC). Following PCR, amplification products were
purified from the reaction mix using Qiagen’s DyeEx 2.0 Spin Kit. Samples were
subsequently evaporated by centrifugation in a centrivap vacuum concentrator
for 30 minutes at room temperature and resuspended in 20µl formamide buffer.
Samples were then loaded onto the ABI 3130 Prism Sequencer.

Microinjection of pUAST-α2NC1:
75µg of pUAST-α2NC1 were sent to Genetic Services Inc. for
microinjection into Drosophila melanogaster embryos.

Genetic Crosses for Overexpression of α2NC1:
Each of the five UAS-α2NC1lines was crossed to each of the ten Gal4
lines shown previously in Table 2.1. Five transgenic males and five virgin Gal4
females were used in each cross, and crosses were kept at 25oC. Once larvae
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were observed, the parental flies were transferred to new vials and kept at 29 oC.
After larvae appeared in the 29oC crosses, parental flies were discarded. F1 flies
were observed using light microscopy and a CO2 plate.

Definition and Synthesis of Leader-α2NC1 (Lα2NC1):
In order to create a leader-α2NC1 (Lα2NC1) construct, the online program
“SignalIP-4.0 Prediction” (http://www.cbs.dtu.dk/services/SignalP/) was used to
predict collagen IV’s leader sequence. The required Lα2NC1 nucleotide
sequence was synthesized in vitro as part of a plasmid (pIDTSmart-Lα2NC1).
15ng of pIDTSmart-Lα2NC1 was used to transform chemically-competent DH5α
E. coli via heat shock, as previously described. Transformants were selected by
plating the transformation reaction on LB-agar with 75µg/mL ampicillin and
growing the cells overnight at 37oC. A single resulting colony was picked and
used to maxiprep large quantities of pIDTSmart-LαNC1 using the Qiagen Spin
Maxiprep Kit according to the manufacturer’s protocol.

Cloning of Lα2NC1 into pUAST:
pIDTSmart-Lα2NC1 and pUAST were each digested with EcoRI (36µg
pIDTSmart-Lα2NC1 or 21µg pUAST, 3µl EcoRI [~30U, Invitrogen], 8µl 10X
Buffer H [Invitrogen], nanopure water to 80µl) and run on a 0.8% agarose gel
with 0.6µg/mL ethidium bromide at 100V for 1hr. The bands corresponding to
Lα2NC1 (1005bp) and pUAST (~9000bp) were excised, and the DNA was
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purified by gel extraction using Qiagen’s Qiaex II Gel Extraction Kit according to
the manufacturer’s protocol. The digested insert and vector were ligated in a 12:1
ratio (43ng digested pUAST, 57ng digested Lα2NC1, 0.5µl T4 DNA Ligase
[200U, NEB], 1µl 10X buffer [NEB], nanopure water to 10µl) overnight at 16oC.
The entire ligation reaction (10µl) was used to transform chemically-competent
DH5α E. coli via heat shock, as previously described. Transformants were
selected by growing the cells overnight at 37oC on LB-agar with 75µg/mL
ampicillin.

Screening of Transformants for Recombinant pUAST-Lα2NC1:
4mL liquid LB/ampicillin (75µg/mL) cultures were inoculated from each of
the nineteen resulting transformants and grown overnight at 37oC/300rpm.
Plasmid DNA was isolated from each of these liquid cultures using Qiagen’s
QIAprep Spin Miniprep Kit according to the manufacturer’s protocol. Plasmid
DNA was then digested with BglII (100ng plasmid DNA, 1µl BglII [~5U,
Invitrogen], 2µl 10X Buffer M [Invitrogen], nanopure water to 20µl) for 2 hours at
37oC (in a thermal cycler) and run on a 0.8% agarose gel with 0.6µg/mL ethidium
bromide at 100V for 1hr. Positive clones were identified and large quantities of
pUAST-Lα2NC1 were generated by maxiprep using Qiagen’s Spin Maxiprep Kit
according to the manufacturer’s protocol.
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Standard Dideoxy Sequencing of pUAST-Lα2NC1:
Sequencing was conducted following a similar protocol as that used for
pUAST-α2NC1. ~50ng of pUAST-Lα2NC1 were used in each sequencing
reaction, and cleanup was achieved by two subsequent isopropanol
precipitations as follows. Four volumes (40µl) of 75% isopropanol were added to
the sequencing reaction followed by centrifugation for 20 minutes in a table top
centrifuge at 21,000Xg. The supernatant was removed and 250µl isopropanol
added, followed by 10 minutes of centrifugation at 21,000Xg. Once again, the
supernatant was removed, and residual liquid was evaporated in a centrivap
vacuum concentrator for 10 minutes at room temperature. Samples were
resuspended in 20µl of formamide buffer and loaded onto the ABI 3130 Prism
Sequencer.

Microinjection of pUAST-Lα2NC1:
75µg of pUAST-Lα2NC1 were sent to Genetic Services Inc. for
microinjection into Drosophila melanogaster embryos.
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Primer
JO1US
JO1DS
UAAS-2
pUASTrev

Use
Amplification of α2NC1
Amplification of α2NC1
Sequencing
Sequencing

Sequence (5’-3’)
TGAATTCATGATTGGATTCCAAGGACAG
ATTCTAGATTACCTGGACTTTGCAGTGCCG
ACCAGCAACCAAGTAAATCAACTGC
GTCACACCACAGAAGTAAGG
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Table 2.1 Primers used for PCR and Sequencing Reactions.

Gal4 Line
Eyeless-Gal4
Panier-Gal4
Scalloped-Gal4
Cg-Gal4
Vestigial-Gal4
Ultra bithorax-Gal4
LSP2-Gal4
Patched-Gal4
GMR-Gal4
Tubulin-Gal4

Expresses in
Eye
Dorsal cells
Wing
Hemocytes
Wing
Thorax, abdomen, wing, haltere
Larval fat body/adult hemolymph
Antero-posterior compartment boundary
Eye
Whole body

Table 2.2. Gal4 Driver Lines. The various driver lines of Drosophila
melanogaster each express Gal4 in a particular tissue/pattern. Breeding these
lines with a UAS-transgene line (i.e. UAS-α2NC1), results in progeny that
overexpress said transgene in the same tissue/pattern (16).
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CHAPTER 3
RESULTS
Successful PCR Amplification of α2NC1 from Viking cDNA:
PCR using Viking cDNA as a template successfully amplified the DNA
fragment corresponding to α2NC1, as shown by the appropriately-sized ~900bp
band observed following gel electrophoresis of the PCR products (Figure 3.1).
Furthermore, the primers used were designed such that they incorporated start
(ATG) and stop (TAA) codons (allowing the α2NC1 gene fragment to be
translated properly in vivo) as well as restriction sites (forward: EcoRI, reverse:
XbaI) to be used in future restriction digests (Figure 3.2). The band
corresponding to the amplified α2NC1 was gel purified for use in the subsequent
cloning steps.

Cloning of α2NC1 into Bluescript II SK+:
Restriction digestion with EcoRI and XbaI resulted in linear Bluescript II
SK+ (BS), as indicated by the appropriately-sized ~3000bp band observed
following gel electrophoresis of the completed digest (Figure 3.3). Along with
double-digested α2NC1 DNA, the linearized BS was used in the subsequent
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ligation reaction to generate BS-α2NC1 (Figure 3.4). Heat shock transformation
of E. coli cells using the ligation reaction resulted in several transformants, as
indicated by the growth of colonies on selective LB-agar/ampicillin medium.

Screening of Transformants Identified Recombinant BS-α2NC1:
Electrophoretic analysis of undigested plasmid DNA isolated from each
transformant suggested that there were several positive BS-α2NC1 clones, as
indicated by the shift in molecular weight seen between empty BS and several of
the samples (Figure 3.5). Digestion of four of these putative BS-α2NC1 samples
with EcoRI and XbaI confirmed their identity, as gel electrophoresis of each
digest resulted in two distinct bands, one corresponding to BS (~3000bp) and the
other to α2NC1 (~900bp) (Figure 3.6).

Subcloning of α2NC1 from BS-α2NC1 to pUAST:
Digestion of BS-α2NC1 with EcoRI and XbaI successfully liberated the
α2NC1 DNA fragment from the vector, as indicated by the two distinct bands
observed following gel electrophoresis of the completed digest (~900bp and
~3000bp, corresponding to α2NC1 and BS, respectively) (Figure 3.7). Doubledigestion of pUAST with the same two enzymes successfully linearized the
vector, as indicated by the ~9000bp band observed following gel electrophoresis
of the completed digest (Figure 3.7). The digested α2NC1 and pUAST fragments
were purified from the gel, and used in the subsequent ligation reaction, which
24

resulted in the creation of recombinant pUAST-α2NC1 (Figure 3.8). Heat shock
transformation of E. coli cells using the ligation reaction resulted in several
transformants, as indicated by their growth on selective LB-agar/ampicillin
medium.

Screening of Transformants Identified Recombinant pUAST-α2NC1:
Electrophoretic analysis of undigested plasmid DNA isolated from each
transformant suggested that nearly all transformants were successful pUASTα2NC1 clones, as indicated by the shift in molecular weight seen between empty
pUAST and all but one of the samples (Figure 3.9). PCR amplification of α2NC1
from one of these putative pUAST-α2NC1 clones confirmed its identity, as gel
electrophoresis of the PCR product yielded a single band at ~900bp (Figure
3.10).

Sequencing of pUAST-α2NC1 Revealed that the α2NC1-Coding DNA in the
Construct is Not Defective:
PCR which incorporated fluorescent ddNTPs amplified α2NC1 DNA from
pUAST-α2NC1, as described in the methods. Half of the reactions utilized primer
UAAS-2, which anneals to the 5’ side of pUAST’s multiple cloning site, near the
UAS. The other half of the sequencing reactions used the primer pUASTrev,
which anneals to the opposite strand of pUAST, just to the 3’ side of the multiple
cloning site. Sequencing analysis was performed by the ABI 3130 Prism
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Sequencer. Reverse complementation was performed on results from pUASTrev
reactions, as this primer amplifies from the nonsense strand. Results were
compared to the nucleotide sequence “Drosophila melanogaster collagen type IV
alpha 2 (DmColA2) mRNA, complete cds” using NCBI’s basic local alignment
search tool (BLAST). Whenever discrepancies were observed between the
results and accepted sequence, it was determined that the quality of sequencing
reads for that region was poor and the sequence was confirmed by proper
alignment in duplicate runs (see example, Figure 3.11). It was ultimately
determined that no errors in cloning or mutations had occurred, and that the
vector contained the proper coding sequence for α2NC1 as well as flanking start
and stop codons.

Generation of UAS-α2NC1 Flies:
pUAST-α2NC1 was sent to Genetic Services Incorporated (GSI) where,
along with a transposase element, it was microinjected into the germ line cells of
Drosophila embryos. Because pUAST contains a P-element, microinjection
resulted in the incorporation of the vector into the fly genome. Inbreeding of these
initial transgenics resulted in animals with the insert present in the genomic DNA
of every cell and tissue. Five viable transgenic UAS-α2NC1 lines (referred to as
“JO1” lines) were received from GSI, of which two were homozygous for UASα2NC1 on the second chromosome and two were homozygous for UAS-α2NC1
on the third chromosome. An additional second chromosome line was
homozygous lethal and therefore balanced over CyO on the second
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chromosome (Table 3.1). Each of these transgenic lines should enable the
overexpression of α2NC1, which for the purposes of these experiments was
defined as amino acids 1450-1749 of the 1761 amino acid collagen IV α2 protein.
These residues contain both α2NC1 and provide extra “contextual” amino acids
that may help maintain α2NC1’s normal folding

Overexpression of α2NC1 in Flies Produces No Developmental Phenotype:
Various Gal4 driver lines of Drosophila melanogaster are available which
drive expression of Gal4 in a tissue-specific pattern. These Gal4 driver lines
contain the gene for Gal4 under the control of various enhancers. Each driver
line therefore expresses Gal4 in a specific pattern based upon its unique
enhancer. For example, vestigial (vg) is a gene expressed primarily in the wing
imaginal disc, along the ventral-dorsal compartment boundary (19). Vg-Gal4 flies
therefore express Gal4 in a similar pattern within the wing. By crossing UASα2NC1 flies with various Gal4 driver lines, the expression of α2NC1 should follow
the same pattern as the Gal4 expression. This allowed us to investigate any
tissue specific effects of α2NC1’s expression. This is an important question to
ask, given that BM composition differs greatly between various organs and
tissues (2,3).
Crosses between the Gal4 drivers lines shown in Table 2.1 and the five
JO1 lines produced no developmental phenotype at 25oC. Crosses conducted at
29oC similarly showed no outstanding characteristics, despite the fact that the
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Gal4 system is temperature sensitive and overexpresses more at higher
temperatures. This lack of effect is likely due to a requirement for extracellular
localization of α2NC1 for its functionality. This possibility will be investigated in
future crosses between UAS-Lα2NC1 (JO2) and Gal4 lines, as these progeny
will overexpress a secreted version of α2NC1.

Definition and Synthesis of Leader-α2NC1 (Lα2NC1):
SignalIP-4.0 Prediction indicated collagen IV α2’s signal peptidase
cleavage site as being between amino acids 28 and 29 (Figure 3.12). In order to
conserve the context of the cleavage site, amino acids 1-35 were chosen to be
joined to aa1450-1749 (α2NC1) of collagen IV. The Lα2NC1 DNA sequence was
created in vitro by Integrated DNA Technologies (IDT) as part of a simple
plasmid (pIDTSmart-Lα2NC1).
The fusion of the leader sequence to α2NC1 should result in the
cotranslational localization of the peptide to the rough endoplasmic reticulum.
Once fed into the ER lumen, α2NC1 will be cleaved from the membrane-bound
leader sequence by signal peptidase. Like other soluble ER-localized peptides,
α2NC1 will be directed to the Golgi apparatus and eventually to the plasma
membrane for export from the cell to its native extracellular location.

Cloning of Lα2NC1 into pUAST:
Digestion with EcoRI liberated the Lα2NC1 DNA fragment from
pIDTSmart-Lα2NC1, as indicated by the two distinct bands observed following
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gel electrophoresis of the completed digest (~1005bp and ~2000bp,
corresponding to Lα2NC1 and pIDTSmart, respectively) (Figure 3.13). Digestion
of pUAST with EcoRI successfully linearized the vector, as indicated by the
~9000bp band observed following gel electrophoresis of the completed digest
(Figure 3.13). These digested fragments were gel purified and used in the
subsequent ligation reaction which resulted in the successful creation of
recombinant pUAST-Lα2NC1 (Figure 3.14). Heat shock transformation of E. coli
cells using the ligation reaction resulted in several transformants, as indicated by
their growth on selective LB-agar/ampicillin medium.

Screening of Transformants Identified Recombinant pUAST-Lα2NC1:
Digestion of plasmid DNA isolated from each transformant identified one
as containing recombinant pUAST-Lα2NC1, as digestion with BglII followed by
gel electrophoresis resulted in two visible bands, one corresponding to pUAST
(~9000bp) and the other to Lα2NC1 (1005bp) (Figure 3.15). This restriction
pattern indicated that Lα2NC1 had inserted in the forward orientation relative to
the UAS in pUAST (Figure 3.16).

Sequencing of pUAST-Lα2NC1 Revealed that the Lα2NC1-Coding DNA in
the Construct is Not Defective:
Sequencing of pUAST-Lα2NC1 was performed in a manner similar to that
used for pUAST-α2NC1. Results were compared using BLAST to the nucleotide
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sequences “Drosophila melanogaster collagen type IV alpha 2 (DmColA2)” and
“viking, transcript variant C” to verify the integrity of the α2NC1 and leader
sequences within pUAST-Lα2NC1. Using the analysis strategy described for
pUAST-α2NC1, it was determined that this construct contained the proper
genetic sequences for both the leader sequence and α2NC1 (Figure 3.17).

Generation of UAS-Lα2NC1 Flies:
pUAST-Lα2NC1 DNA was sent to Genetic Services Incorporated (GSI)
where, it was microinjected into Drosophila embryos, as described for the
microinjection of pUAST-α2NC1. These flies will contain a leader-α2NC1 fusion
sequence, again under the control of a UAS. The added leader sequence should
direct the overexpressed α2NC1 peptide to the endoplasmic reticulum so that it
can be exported from the cell to its native extracellular location.
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Figure 3.1. PCR Amplification of α2NC1 DNA. PCR successfully amplified the
genetic sequence for α2NC1. The PCR products were run on a 0.8% agarose gel
with 0.6µg/mL at 100V for 1hr, which yielded a single band of the appropriate
size (~900bp) (lanes 3 and 5). Lane 1 contains a standard 1kB+ DNA Ladder
(Invitrogen). The PCR product was excised and subsequently purified using
Qiagen’s Qiaex II Gel Extraction Kit.
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Figure 3.2. Primers Used to Amplify α2NC1 from Viking Incorporated Start/Stop Codons and Restriction
Sites. The primers shown above were designed to anneal to the forward and reverse strands of Viking cDNA ,
flanking the base pairs corresponding to amino acids 1450-1749 (NC1) of collagen IV α2. The forward primer
incorporated a start codon (ATG) and EcoRI restriction site (GAATTC). The reverse primer incorporated a stop
codon (TTA-reverse complement) and XbaI restriction site (TCTAGA). Figure not to scale.
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Figure 3.3. Double-Digestion of BS and α2NC1. 40µg of BS and 1µg of PCRamplified α2NC1 DNA were digested with EcoRI and XbaI. Digests were run on a
0.8% agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Lanes 1-3
contain digested α2NC1. Lanes 4-6 contain digested (linear) BS. Digested BS
and α2NC1 DNA were purified from the gels using Qiagen’s Qiaex II Gel
Extraction Kit for use in the subsequent ligation reaction to create BS-α2NC1.
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Figure 3.4. BS-α2NC1. Bluescript was used as an initial carrier for the α2NC1
genetic sequence, as it is much smaller than pUAST and therefore easier to use
in the cloning reaction. The completed BS-α2NC1 plasmid contained an
ampicillin resistance gene in addition to a bacterial origin of replication and the
inserted α2NC1 genetic sequence, which was flanked by EcoRI and XbaI sites.
Large quantities of BS-α2NC1 were generated and digested in order to produce
the α2NC1 DNA needed for cloning into pUAST (20)

34

1

2

3

4

5

6

7

8

9

10

11 12

13

14 15 16 17

Figure 3.5. Putative BS-α2NC1 Clones. Plasmid DNA isolated from various
clones via miniprep was run on a 0.8% agarose gel at 100V for 1hr. For
comparison, lane 2 contains supercoiled BS DNA. The gel shift seen between
the bands in lane 2 and those in lanes 3-9, 13, 15, and 16 indicates that these
are most likely recombinant (BS-α2NC1) molecules. Lanes 10, 12, and 14
appear to contain empty vector, and the molecule represented in lane 11 is
possibly a BS molecule that incorporated two copies of α2NC1. Lane 17 contains
nanopure H2O.
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Figure 3.6. Digestion of Putative BS-α2NC1 Clones. Four putative BS-α2NC1
clones (see Figure 3.5) were digested with EcoRI and XbaI in order to liberate
the incorporated α2NC1 fragment and confirm their identity. Digests were run on
a 0.8% agarose gel with 0.6µg/mL at 100V for 1hr. For comparison, lane 2
contains digested BS (empty). Lanes 3-5 are clearly BS-α2NC1, as bands
corresponding to BS (~3000bp) and α2NC1 (~900bp) are easily visible. The
clone represented in lane 6 is also most likely BS-α2NC1, but the presence of an
additional band just below 3000bp raises some question; the additional band is
most likely a result of star activity, which was seen in some other digests due to
the fact that EcoRI functions non-ideally in the medium-salt XbaI buffer that was
used for the double-digestion. The clone represented in lane 4 was selected for
future use.
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Figure 3.7. Double-Digestion of pUAST and BS-α2NC1. 42.5µg of pUAST and
47.3µg of BS-α2NC1 were digested with EcoRI and XbaI. Each digest was run
on a 0.8% agarose gel with 0.6µg/mL at 100V for 1hr. A) Lanes 3-5 contain
digested (linear) pUAST. Lane 6 contains nanopure water. B) Lanes 2-5 contain
digested BS-α2NC1 (upper band is linear BS ~3000bp and lower band is α2NC1
~900bp). Lane 6 contains nanopure water. Digested pUAST and α2NC1 DNA
was purified from the gels using Qiagen’s Qiaex II Gel Extraction Kit for use in
the subsequent ligation reaction to create pUAST-α2NC1.
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Figure 3.8. pUAST-α2NC1. This vector contained a gene for ampicillin
resistance, a bacterial origin of replication, and the gene fragment for α2NC1 just
downstream of the UAS (“5xGal4 DBD”). This vector was microinjected into
Drosophila embryos, and due to its P element capability, it integrated into the
genome, resulting in five lines of UAS-α2NC1 or “JO1” flies (20)
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Figure 3.9. Putative pUAST-α2NC1 Clones. Plasmid DNA isolated from various
clones via miniprep was run on a 0.8% agarose gel with 0.6µg/mL at 100V for
1hr. For comparison, lane 1 contains supercoiled pUAST DNA. The gel shift seen
between the bands in lane 1 and those in lanes 2-8 and 10-19 indicates that
these are most likely recombinant (pUAST-α2NC1) molecules. The identity of the
band in lane 9 is unknown.
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Figure 3.10. PCR Amplification of α2NC1 from a Putative Clone Confirms Its
Identity as pUAST-α2NC1. PCR successfully amplified the α2NC1 genetic
sequence from one of the putative pUAST-α2NC1 clones seen in Figure 3.6. The
PCR products were run on a 0.8% agarose gel with GelRed (Biotium) at 100V for
1hr, and the ~900bp band corresponding to α2NC1 is easily visible in lane 2.
Lane 1 contains a 1kB+ DNA Ladder (Invitrogen).
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Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA, complete cds
Query

88

Sbjct

4509

ACAGAGAGGTGCCGTCGGATATCGCGCCCGACCAGGGCGAGGTGGGCTACACCGGAGCCG
||||||||||||||||||||||||||
|||||||||||||||||||||||||||||||
ACAGAGAGGTGCCGTCGGATATCGCG-GTGACCAGGGCGAGGTGGGCTACACCGGAGCCG

147
4567

Figure 3.11. Sequencing of pUAST-α2NC1. Above are representative sequencing results for pUAST-α2NC1.
Results were compared using BLASTn to “Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA,
complete cds.” Mismatches typically corresponded to poor sequencing reads (see yellow highlighted reads above).
Duplicate sequencing reactions were performed in order to obtain enough good reads to confirm that the entire
α2NC1 sequence was correct.
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Figure 3.12. Cleavage Prediction. The online “SignalIP-4.0 Prediction” software was used to predict which amino
acids comprise the leader peptide that targets collagenIVα2 for translation at the rough ER and eventual secretion
from the cell. The output above shows three scores. The C score is highest at the position predicted to be just after
the cleavage site. The S score (green) is high for those residues thought to comprise the leader sequence. The Y
score (blue) is a combination of the C and S scores and peaks at the most likely cleavage sites. Based on this
output, the most likely cleavage site is between residues 27 and 28, with a second potential site between residues
30 and 31. As such, amino acids 1-35 were chosen for fusion with the C-terminal α2NC1 domain. When this fused
protein (Lα2NC1) is expressed in vivo, the leader should be cleaved off by a signal peptidase in the ER, and
α2NC1 will be exported to the extracellular space where it can enact its biological functions.
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Figure 3.13. Digestion of pIDTSmart-Lα2NC1 and pUAST. pIDTSmartLα2NC1 and pUAST were digested with EcoRI. Each digest was run on a 0.8%
agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Lane 1 contains a
standard 1kb+ DNA ladder (Invitrogen). Lanes 2 and 3 contain digested
pIDTSmart-Lα2NC1 (upper band is linear pIDTSmart (~2000bp) and lower band
is Lα2NC1 ~1000bp). Lanes 4 and 5 contain digested (linear) pUAST (~9000bp).
Lane 6 contains nanopure water. Digested pUAST and Lα2NC1 DNA was
purified from the gel using Qiagen’s Qiaex II Gel Extraction Kit for use in the
subsequent ligation reaction to create pUAST-Lα2NC1.
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Figure 3.14. pUAST-Lα2NC1. This vector contained a gene for ampicillin
resistance, a bacterial origin of replication, and the genetic sequence coding for a
leader peptide and α2NC1 (Lα2NC1) just downstream of the UAS (“5xGal4
DBD”). This vector was sent to Genetic Services Incorporated for microinjection
into Drosophila embryos, and due to its P element capability, it will integrate into
the genome, resulting in transgenic lines of UAS-Lα2NC1 or “JO2” flies (20)
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Figure 3.15. Digestion of Potential pUAST-Lα2NC1 Clones. Eighteen putative
BS-α2NC1 clones (only 6 shown) were digested with BglII in order to liberate the
incorporated Lα2NC1 fragment and so identify any recombinant (pUASTLα2NC1) molecules. Digestion with BglII (as opposed to the enzyme used to
clone [EcoRI]) allowed for directional screening, to ensure proper orientation of
the inserted Lα2NC1 fragment (see Figure 2.2). Digests were run on a 0.8%
agarose gel with 0.6µg/mL ethidium bromide at 100V for 1hr. Lane 1 contains a
standard 1kB+ DNA ladder (Invitrogen). For comparison, lane 2 contains
digested pUAST (empty). Lane 4 is clearly pUAST-Lα2NC1, as bands
corresponding to pUAST (~9000bp) and Lα2NC1 (1005bp) are easily visible.
Lanes 5-9 appear to be empty pUAST. Lane 10 is nanopure water.
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Figure 3.16. Digestion with BglII Can Identify Orientation of LαNC1. The construct on the left shows Lα2NC1 in
the proper orientation relative to the UAS (“5XGal4 DBD”). As shown by the marked restriction sites, digestion of
this molecule with BglII would result in three fragments, 80bp, 914bp, and 8921bp. If Lα2NC1 inserted in the
reverse orientation (right), fragments 80bp, 29bp, and 9806bp long would be expected following BglII digestion (20)
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Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA, complete cds
Leader:

α2NC1:

Query

67

Sbjct

154

Query

172

Sbjct

ATGTTACCCAGAGAACAAAGGGATCTCTCGGGTCTTCTGGGCGTCGTTTATCTGTTGGGC
|||||||||||||| | |||| ||||||||||||||| ||||||||||||||||||||||
ATGTTACCCAGAGATCTAAGGCATCTCTCGGGTCTTCCGGGCGTCGTTTATCTGTTGGGC

126

ATTGGATTCCAAGGACAGAGAGGTGCCGTCGGATATCGCGGTGACCAGGGCGAGGTGGGC
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4495 ATTGGATTCCAAGGACAGAGAGGTGCCGTCGGATATCGCGGTGACCAGGGCGAGGTGGGC

231

213

4554

Figure 3.17. Sequencing of pUAST-Lα2NC1. Above are representative sequencing results for pUAST-Lα2NC1.
Results were compared using BLASTn to “Drosophila melanogaster collagen type IV alpha 2 (DmColA2) mRNA,
complete cds.” Mismatches typically corresponded to poor sequencing reads (see yellow highlighted reads above).
Duplicate sequencing reactions were performed in order to obtain enough good reads to confirm that both parts of
the Lα2NC1 sequence were correct.

Line
JO1L1
JO1L2
JO1L3
JO1L4
JO1L5

Chromosome
III, homozygous
III, homozygous
II, homozygous
II, balanced over CyO
II, homozygous

Table 3.1. JO1 Transgenic Lines. Five lines of transgenic Drosophila
melanogaster were received from Genetic Services Incorporated following
microinjection of pUAST-α2NC1.
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CHAPTER 4

DISCUSSION

Three recombinant vectors were generated as a result of this work. The
first of these (BS-α2NC1) was generated by cloning of the genetic sequence for
α2NC1 into the multiple cloning site of the common laboratory vector Bluescript II
SK+. α2NC1 DNA was generated by PCR amplification of corresponding region
from Viking cDNA (Viking being the Drosophila melanogaster gene for the full α2
chain of collagen IV). The primers used for PCR were designed to incorporate
start and stop codons (allowing the α2NC1 gene fragment to be translated
properly in vivo) as well as restriction sites (EcoRI and XbaI, to be used in
cloning) on either side of the α2NC1 sequence. Double-digestion of the PCR
product and Bluescript SK+ with said enzymes, followed by ligation using T4
DNA ligase, successfully produced the recombinant BS-α2NC1 molecule.
The second vector was pUAST-α2NC1, which was generated by
subcloning of the α2NC1 genetic sequence from BS-α2NC1 to the Drosophila
vector pUAST. Digestion of pUAST and excision of α2NC1 from BS-α2NC1 were
carried out using the same enzymes as before (EcoRI and XbaI), ensuring that
αNC1 was ligated into pUAST in the forward orientation relative to pUAST’s
upstream activation sequence (UAS).
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The third and final construct, pUAST-Lα2NC1, contained the genetic
sequence for a leader-α2NC1 fusion construct under the control of pUAST’s
UAS. The native α2-chain leader sequence was determined, and the Lα2NC1
fusion sequence (with flanking EcoRI sites) was synthesized in vitro as part of a
simple bacterial plasmid. Restriction digestion with EcoRI excised the Lα2NC1
fragment from said plasmid, and ligation with EcoRI-digested pUAST resulted in
recombinant pUAST-Lα2NC1. Due to the use of a single enzyme in this cloning
procedure, several plasmid molecules resulting from the ligation were merely
empty pUAST that had not incorporated an insert, and one was found to be
pUAST that incorporated Lα2NC1 in the reverse orientation relative to the UAS.
However, a second round of ligation resulted in a pUAST-Lα2NC1 molecule with
Lα2NC1 in the proper orientation.
The two pUAST constructs were sent to Genetic Services Incorporated
where they were microinjected into Drosophila melanogaster embryos, resulting
in transgenic animals containing α2NC1 under the control of an upstream
activation sequence (UAS). Five lines of UAS-α2NC1 (JO1) flies were received
from GSI (see Table 3.1), and mapped UAS-Lα2NC1 (JO2) lines are expected to
be received in the near future.
The creation of these transgenic lines is the first critical step in this study
of α2NC1 in organismal development and tumorigenesis, as they have and will
allow for the Gal4-dependent tissue-specific overexpression of α2NC1 in wildtype and tumor-bearing flies. Crosses between each of the five UAS-α2NC1
(JO1) lines and ten different Gal4 driver lines (see Tables 3.1 and 1.1) all
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produced viable offspring with no observed phenotypic abnormalities. The
absence of an effect was surprising; it was expected that, given the critical role of
BM in Drosophila development, perturbing its composition would result in lethality
or improper/incomplete development of various structures, depending on the
expression pattern in question.
However, there are potential explanations for the lack of developmental
phenotype. First, in order to rule out the possibility that α2NC1 was not being
overexpressed as expected, reverse transcription PCR will be used to quantify
α2NC1 RNA levels in overexpressing versus wild type flies. Assuming that
α2NC1 levels are indeed significantly more robust in the overexpressing flies,
one likely reason for the lack of phenotype could be the improper localization of
α2NC1 from UAS- α2NC1. Because basement membrane is extracellular in
nature and because α2NC1 is derived from the BM, it is logical to infer that
α2NC1 should be localized to the outside of the cell. The extracellular localization
of collagen IV is dependent on the N-terminal signal peptide. However, α2NC1 is
a C-terminal domain of collagen IV, and as part of the UAS- α2NC1 construct
does not contain the amino acid sequence that directs the α-chain to the
endoplasmic reticulum during translation and thereby targets it for secretion from
the cell. Therefore, it is very likely that the recombinant α2NC1 being
overexpressed in the JO1 X Gal4 progeny is located in the cytoplasm where it is
unable to exert its effects (such as binding to the extracellular domains of α3 and
αv integrins). In the near future, crosses between UAS-Lα2NC1 (JO2) and Gal4
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flies will test this hypothesis, as these progeny will overexpress a leader
sequence-α2NC1 fusion molecule that will target α2NC1 for secretion.
In said JO2 X Gal4 crosses, it is expected that distinct developmental
abnormalities will be observed as a result of abundant extracellular α2NC1
which, based upon previous work, is likely to disrupt formation of basement
membrane and decrease branching of the tracheal system. Branching of the
tracheal system (whose vessels deliver oxygen to various tissues) in Drosophila
has been shown to be in many ways homologous to the mammalian process of
angiogenesis (21). For this reason, the list of Gal4 drivers may be expanded to
include a btl-Gal4 line which will drive expression of α2NC1 in the tracheal cells
themselves. Furthermore, in order to test the hypothesis that α2NC1
overexpression (resulting from JO2 X Gal4 crosses) will diminish formation of
tracheal vessels, studies may be conducted in which larvae are stained via
immunohistochemistry with a labeled anti-2A12 antibody, a marker used in other
studies to specifically identify tracheal cells (22).
In tumorigenesis studies, it is expected that α2NC1 overexpression will
result in fewer and smaller tumors (again likely due to disrupted BM formation
and decreased tracheal branching), and future experiments will work to
investigate the mechanism of such results.
Other future studies may involve the creation of α2NC1 transgenics with a
fluorescent or antigen tag, so that localization of α2NC1 can be seen within the
fly and on a smaller scale, it’s (extra)cellular location. Furthermore, we would like
to conduct further overexpression studies in order to investigate the
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developmental and tumorigenic roles of other collagen IV fragments (such as the
N-terminal 7S domain) as well as other basement membrane molecules; for
example, collagens, laminin, SPARC, and perlecan, have all been shown in other
studies to be bioactive and regulators of angiogenesis (2,3).
These investigations will shed light upon the numerous interactions that
take place during basement membrane remodeling, both in normal
developmental situations and during the invasive processes of tumor
angiogenesis and metastasis, and thus will contribute toward the ultimate goal of
fully understanding and combating tumor development and progression in
patients diagnosed with cancer.
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ABBREVIATIONS NOT LISTED IN TEXT

SPARC................................................ secreted protein acidic and rich in cysteine
FLIP............................................................................ FLICE-like inhibitory protein
FAK...................................................................................... focal adhesion kinase
PI3K............................................................................... phosphoinositide 3-kinase
Bcl-2......................................................................... B-cell lymphoma 2 (a protein)
Bax................................................................................ Bcl-2-associated X protein
PCR.............................................................................. polymerase chain reaction
dNTP.................................................................. dexoyribonucleotide triphosphate
LB....................................................................................................... Luria-Bertani
ddNTP............................................................. dideoxyribonucleotide triphosphate
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